Oncogene - Table of Contents alert Volume 31 Issue 42

TABLE OF CONTENTS Volume 31, Issue 42 (October 2012) In this issue Review Original Articles Oncogenomics Also new AOP Advertisement Finally! Antibodies you can trust. Diagenode has revolutionized immunoprecipitation with a novel, rigorous antibody classification system. Since 2003, we are the only company to have worked closely with experts in the epigenetics community to develop the absolute best epigenetics reagents and antibodies. Have confidence in the antibodies you choose. Achieve unparalleled ChIP and ChIP-seq results with antibodies you can trust. Learn more. Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Read this article recently published in Molecular Systems Biology Systematic RNA interference perturbations within ovarian cancer cells reveal a hierarchically organized transcription factor network downstream of the oncogenic RAS pathway. Modules within the network are shown to control distinct aspects of cell growth and migration. Reverse engineering a hierarchical regulatory network downstream of oncogenic KRAS OPEN Iwona Stelniec-Klotz, Reinhold Schäfer et al   Review Top Interaction of tumor cells and lymphatic vessels in cancer progression A Alitalo and M Detmar Oncogene 2012 31: 4499-4508; advance online publication, December 19, 2011; 10.1038/onc.2011.602 Abstract | Full Text Original Articles Top MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers B Zheng, L Liang, S Huang, R Zha, L Liu, D Jia, Q Tian, Q Wang, C Wang, Z Long, Y Zhou, X Cao, C Du, Y Shi and X He Oncogene 2012 31: 4509-4516; advance online publication, December 19, 2011; 10.1038/onc.2011.581 Abstract | Full Text Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression A Petrelli, A Perra, K Schernhuber, M Cargnelutti, A Salvi, C Migliore, E Ghiso, A Benetti, S Barlati, G M Ledda-Columbano, N Portolani, G De Petro, A Columbano and S Giordano Oncogene 2012 31: 4517-4526; advance online publication, January 16, 2012; 10.1038/onc.2011.631 Abstract | Full Text A novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growth W Huang, Y Fridman, R D Bonfil, C V Ustach, M K Conley-LaComb, C Wiesner, A Saliganan, M L Cher and H-R C Kim Oncogene 2012 31: 4527-4535; advance online publication, December 12, 2011; 10.1038/onc.2011.573 Abstract | Full Text Dual role of the ddx5/ddx17 RNA helicases in the control of the pro-migratory NFAT5 transcription factor S Germann, L Gratadou, E Zonta, E Dardenne, B Gaudineau, M Fougère, S Samaan, M Dutertre, S Jauliac and D Auboeuf Oncogene 2012 31: 4536-4549; advance online publication, January 23, 2012; 10.1038/onc.2011.618 Abstract | Full Text Dietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature C Taccioli, H Chen, Y Jiang, X P Liu, K Huang, K J Smalley, J L Farber, C M Croce and L Y Fong Oncogene 2012 31: 4550-4558; advance online publication, December 19, 2011; 10.1038/onc.2011.592 Abstract | Full Text A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer E S Ratner, F K Keane, R Lindner, R A Tassi, T Paranjape, M Glasgow, S Nallur, Y Deng, L Lu, L Steele, S Sand, R-U Muller, E Bignotti, S Bellone, M Boeke, X Yao, S Pecorelli, A Ravaggi, D Katsaros, D Zelterman, M C Cristea, H Yu, T J Rutherford, J N Weitzel, S L Neuhausen, P E Schwartz, F J Slack, A D Santin and J B Weidhaas Oncogene 2012 31: 4559-4566; advance online publication, December 5, 2011; 10.1038/onc.2011.539 Abstract | Full Text Oncogenomics Top Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling C Zeller, W Dai, N L Steele, A Siddiq, A J Walley, C S M Wilhelm-Benartzi, S Rizzo, A van der Zee, J A Plumb and R Brown Oncogene 2012 31: 4567-4576; advance online publication, January 16, 2012; 10.1038/onc.2011.611 Abstract | Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.